Your browser doesn't support javascript.
loading
Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors.
Yekedüz, Emre; Köksoy, Elif Berna; Yazgan, Sati Coskun; Karatas, Göktürk; Senler, Filiz Çay; Utkan, Güngör; Akbulut, Hakan; Demirkazik, Ahmet; Ürün, Yüksel.
Afiliação
  • Yekedüz E; Department of Medical Oncology, Faculty of Medicine.
  • Köksoy EB; Cancer Research Institute.
  • Yazgan SC; Department of Medical Oncology, Faculty of Medicine.
  • Karatas G; Cancer Research Institute.
  • Senler FÇ; Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Utkan G; Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Akbulut H; Department of Medical Oncology, Faculty of Medicine.
  • Demirkazik A; Cancer Research Institute.
  • Ürün Y; Department of Medical Oncology, Faculty of Medicine.
Anticancer Drugs ; 33(10): 1145-1149, 2022 11 01.
Article em En | MEDLINE | ID: mdl-35946564
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus / Hiperglicemia / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus / Hiperglicemia / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article